How long do Phase III clinical trials typically run?

Question

BlackTom AI · Accepted Answer

Phase III clinical trials typically last 1–4 years because they are large, multicenter studies designed to confirm efficacy and monitor safety over meaningful follow-up periods.

1) Relevant knowledge points and concepts
- Clinical trial phases: Phase I (safety, small N), Phase II (preliminary efficacy, dose finding), Phase III (confirmatory efficacy and safety, large N), Phase IV (post‑marketing surveillance).
- Phase III characteristics: many sites, hundreds to thousands of participants, longer enrollment windows, prespecified clinical endpoints that often require months to years of follow‑up, and time for data cleaning and regulatory submission.

2) Step‑by‑step reasoning
- A Phase III trial must enroll a large sample and then observe participants for the endpoint (e.g., disease recurrence, survival, long‑term adverse events).
- Enrollment itself can take 12–24 months or more; each participant may need 6–24 months of follow‑up; then add data analysis and reporting time.
- Combining these elements gives a typical overall duration in the 1–4 year range.

3) Example calculation with intermediate steps
- Example: enrollment period = 18 months; required follow‑up per participant = 12 months; final data cleaning/analysis = 4 months. Total = 18 + 12 + 4 = 34 months ≈ 2.8 years, which lies within 1–4 years.

4) Why the correct answer is correct
- The 1–4 year range reflects common real‑world Phase III timelines that include enrollment, follow‑up, and analysis. It captures the variability between faster trials and those needing longer observation.

5) Why other options are incorrect
- a. 1–10 years: too broad; includes rare, exceptionally long trials and post‑marketing studies, not typical Phase III.
- b. Several months to a year: too short for large confirmatory trials with meaningful clinical endpoints.
- d. 1–2 years: may be true for some faster trials but is narrower than the commonly observed range.

6) Conclusion
- The correct answer is c. 1–4 years, which matches the provided answer.

How long do Phase III clinical trials typically run?Single choice

Similar Questions

Multiple Choice: In which of the following cases would a randomized controlled trial be required to show efficacy of a probiotic supplement?

Which phase of clinical trials primarily aims to evaluate the efficacy and optimal dose of a new treatment in patients with the target disease?

Why is Australia an attractive location for conducting Phase I clinical trials?

Which member of the clinical trial team is responsible for the overall conduct of the trial at a study site?

Which clinical trial design involves assigning participants to different treatment groups, where each group receives only one treatment throughout the study?

Adverse events are difficulties that participants reported about the interventions provided in the study. These are listed in the Results section. Based on what was reported in final paragraph of the results section, select from the list below which adverse event were reported by participants.

What is the typical probability of success for a drug in Phase 1 trials ?

More Practical Tools for Students Powered by AI Study Helper

Homework AI Solver

Stylized AI Paper Writer

Plagiarism Checker Assistant

Citation AI Academic Writing Tool

In-Class Translation Assistant

AI Note Generator

AI Quiz Answers

Past Exam Questions from University Test Bank

Smart Practice Assistant

Adaptive Practice

Making Your Study Simpler